Label Changes for:

Lipofen (fenofibrate) Capsules

December 2008

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

 

Sections Modified

Summary of Changes to Contraindications and Warnings

WARNINGS

  • Other Considerations

PRECAUTIONS

  • Venothromboembolic Disease

WARNINGS

  • ...the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study was

The latest label (approved 12/12/2008) is not available on this site

Hide
(web3)